Erich H. Bozenhardt

United Therapeutics
Associate Director Process Engineering, Regenerative Medicine
Erich Bozenhardt is a BioProcess SME and internationally recognized authority in the domains of cell and gene therapy and bioprocessing. He is a Associate Director Process Engineer in Regenerative Medicine Operations, at United Therapeutics Corporation. During his career, Erich has led the process activities for several biopharmaceutical projects, provided internal and external project leadership, is a published author of more than 30 technical papers, and a conference presenter on process technologies and operations. He is an active member of several Communities of Practice and a contributor to guidance documents. He is the Chair of the ISPE ATMP Community of Practice (CoP).

Related Articles

Building Resilience in Atmp Manufacturing: Insights and Innovations at the 2025 ISPE Aseptic Conference
iSpeak Blog
Building Resilience in ATMP Manufacturing: Insights and Innovations at the 2025 ISPE Aseptic Conference

Advanced therapy medicinal products (ATMPs) are medicines based on genes, tissues, or cells. This class of products cannot be terminally sterilized and, in many cases, cannot be filtered and are manufactured by Aseptic processing. The increase in demand for these life-changing products has been fraught with technical and regulatory challenges as laboratory processes are scaled to commercial...

ISPE Launches ATMP Community of Practice
Insights
ISPE Launches ATMP Community of Practice

“The only constant in life is change.” This quote is as true today as it was 2,500 years ago when Heraclitus laid out his philosophy. In the last five years, the word “cure” has been used to describe new therapies targeting many different cancer and hereditary diseases. The potential of these therapies to improve human health is profound. These breakthrough therapies utilize advancements in...